Obesity impairs body's 'memory' of how to fight flu: study

March 16, 2010

(PhysOrg.com) -- Obesity may limit the body's ability to develop immunity to influenza viruses, particularly secondary infections, by inhibiting the immune system’s ability to "remember" how it fought off previous similar bouts of illness, according to new research from the University of North Carolina at Chapel Hill.

The results, published in the March 15, 2010, issue of The Journal of Immunology, support recent suggestions by the Centers for Disease Control and Prevention that is as much a risk factor for H1N1 pandemic strains of flu as age (very young and very old) and compromised immunity.

Nutrition researchers in the UNC Gillings School of Global Public Health have shown that obese mice are not able to develop protective influenza-specific memory T cells. These cells are generated by the body during an initial infection. They help protect against a second infection by targeting internal proteins common among most strains of influenza viruses. Leaner mice were able to develop the infection-fighting T cells and ward off a second bout of influenza.

“Our work suggests that obese people should be considered at high risk for infection,” said Erik Karlsson, doctoral candidate in nutrition and lead author of the study.

The researchers infected lean and obese mice with a mild . The lean mice had been fed a low-fat diet, and obese mice had been fed a high-fat diet. When the mice recovered from the first bout of flu, they were infected a second time, with a larger dose of a more lethal influenza strain.

“We lost none of the lean mice, but 25 percent of obese mice died,” Karlsson said.

This research builds on a study published in The Journal of Nutrition in 2007. Melinda Beck, Ph.D., UNC professor of nutrition, is the senior author of both studies.

“In the first study, we compared the response of obese and lean mice to a primary influenza infection,” Beck said. “We found that obese mice had a significantly higher mortality rate than lean mice. In fact, 42 percent of obese mice died, while only 5.5 percent of lean mice died.”

During flu seasons, health-care practitioners often see obese patients who struggle more with influenza viruses than leaner patients. Some researchers and doctors have speculated that excess adipose tissue, or fat, constricts lung volume, or that obesity causes chronic inflammation, which influences the immune response.

However, Beck and her colleagues hypothesized the illness’ increased severity may be due to lower memory T cell defenses in obese patients.

“In a healthy individual, memory T cells would be produced during the initial ,” she said. “Those cells help protect the individual from a second infection. The response is different from a vaccine, which produces antibodies against a specific strain. The memory T cells target internal proteins common to all strains of the virus. But if the body can’t produce these during a primary infection, then the individual has decreased protection from a second infection if the antibody response is not targeted towards the infecting strain.”

The new study, by Karlsson, Beck and Patricia Sheridan, Ph.D., UNC research assistant professor of nutrition, shows strong evidence that obesity restricts memory T cell function.

“This kind of novel research could influence public health by changing our views of what the risks factors of obesity are,” Karlsson said. “The risks are potentially much more complicated than we’ve thought.”

The next step in Beck’s research on obesity effects on influenza is to examine vaccination. In collaboration with researchers in the UNC School of Medicine, Beck’s laboratory is running a large National Institutes of Health-sponsored human clinical trial to test the efficacy of influenza vaccination in obese adults.

The next step in Beck’s research on obesity effects on influenza is to examine vaccination. In collaboration with researchers in the UNC School of Medicine, Beck’s laboratory is running a large National Institutes of Health-sponsored human clinical trial to test the efficacy of influenza vaccination in obese adults.

More information: The Journal of Immunology Web site: http://www.jimmunol.org/

Provided by University of North Carolina at Chapel Hill


Rank 5 /5 (2 votes)
Relevant PhysicsForums posts
  • Is Everyday Technology Killing Us?
    createdFeb 08, 2012
  • Exercise and weight loss
    createdFeb 08, 2012
  • Why do we have head aches? Our brains can't feel anything.
    createdFeb 07, 2012
  • "The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
    createdFeb 04, 2012
  • Oncolytic adenovirus
    createdFeb 04, 2012
  • Nutrition label stuffs and diets
    createdFeb 02, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Seeing colors in music, tasting flavors in shapes may happen in life's early months

Famed violinist Itzhak Perlman sees a deep forest green whenever he plays a B-flat on his Stradivarius' G string. The A on the E string is red.

Medicine & Health / Psychology & Psychiatry

created 1 hour ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Team isolates nerve cells involved in storing long term memory and gene proteins associated with them

(Medical Xpress) -- A research team in Taiwan has succeeded in isolating two nerve cells in fruit fly brains that are believed to be the major players in allowing for the formation of long term memories. Furthermore, ...

Medicine & Health / Neuroscience

created 25 minutes ago | popularity 5 / 5 (2) | comments 0 | with audio podcast report

News of plaque-clearing drug tops week of major advances against Alzheimer's disease

In the last eight days, scientists have delivered a powerful one-two punch in the fight to defeat Alzheimer's disease. At the same time, the White House and members of Congress are proposing increases in Alzheimer's research ...

Medicine & Health / Diseases

created 21 minutes ago | popularity not rated yet | comments 0

S.Africa in $208 mln AIDS drug venture with Swiss Lonza

South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs.

Medicine & Health / HIV & AIDS

created 34 minutes ago | popularity not rated yet | comments 0

Russia sounds alarm over spiralling teenage suicides

Top Russian psychiatrists on Friday called for urgent measures to battle the soaring teenage suicide rate, one of the world's highest.

Medicine & Health / Psychology & Psychiatry

created 14 minutes ago | popularity not rated yet | comments 0


The power of estrogen -- male snakes attract other males

A new study has shown that boosting the estrogen levels of male garter snakes causes them to secrete the same pheromones that females use to attract suitors, and turned the males into just about the sexiest ...

Could Venus be shifting gear?

(PhysOrg.com) -- ESA’s Venus Express spacecraft has discovered that our cloud-covered neighbour spins a little slower than previously measured. Peering through the dense atmosphere in the infrared, the ...

Experts reveal how plants don't get sunburn

(PhysOrg.com) -- Experts at the University of Glasgow have discovered how plants survive the harmful rays of the sun.

Engineering images bring life to submerged city

(PhysOrg.com) -- Photo-realistic 3D mapping and digital reconstruction of an ancient underwater city in Greece have earned a team from the University of Sydney's Faculty of Engineering and Information Technologies ...

New power source discovered

(PhysOrg.com) -- Researchers at the Massachusetts Institute of Technology (MIT) and RMIT University have made a breakthrough in energy storage and power generation.

The turbulent birth of super star clusters in galaxy mergers

By combining two of the most advanced telescopes in the world -- the new Atacama Large Millimeter Array (ALMA) and the Very Large Telescope (VLT) of ESO -- a team of French astronomers from the Institut d'astrophysique ...